We are monitoring the impact of COVID-19 on Haemostatic Agents Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4371
Share on
Share on

Global Haemostatic Agents Market Size, Share, Trends and Growth Analysis Report – Segmented By Type, Treatment, End-User, and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4371
Pages: 185

Global Haemostatic Agents Market Size (2020 to 2025)

The global market size for Haemostatic Agents Market is estimated to grow at a CAGR of 7.2% from 2019 to 2024.

Haemostatic Agents refer to the class of substances usually used to promote haemostasis or stop bleeding. Haemostats are the technical term given to instruments used to reduce or halt bleeding during a surgical procedure.

The significant technological advancements in the field have increased haemostats' usage in surgical procedures in recent times. Common problems faced by haemostats include tissue contamination and ease of use. These have been addressed in the latest wave of innovations. The other significant factors affecting the Haemostatic Agents market include the rising prevalence of diseases and increasing awareness regarding the latest medical practices. Other drivers have increasing health consciousness among consumers, the use of new inventions, and enhanced technologies.

Growth opportunities for the Haemostatic Agents Market lie in increasing awareness over the usage of hemostats instruments worldwide. The rise in the demand for surgical procedures to treat various diseases is likely to outshine the market's need. Escalating expenditure on health care, especially in urban areas, boosts the growth rate of haemostatic agents market. Growing tendency to improve the services in hospitals and promote the well-being of the patient after treatment is ascribed to bolster the market's demand. Increasing geriatric population is also one of the factors propelling the growth rate of the haemostatic agents market. The rise in the number of people suffering from chronic diseases like cancer, ophthalmic injuries and replacement, diabetes, urological disorders, and many others where there is a particular need for surgical procedures is propelling the market's demand to the extent.

As for the market's restraints, the high costs and the unfavorable reimbursement policies are the major hurdles. It, along with the fact that people are not aware of the latest developments in developing and underdeveloped countries restrain market growth.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Treatment, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global haemostatic agents market has been segmented and sub-segmented based on the type, treatment, end-user, and region.

Haemostatic Agents Market – By Type:

  • Thrombin Based Haemostats          
  • Gelatin Based Haemostats               
  • Collagen Based Haemostats            
  • Oxidized Regenerated Cellulose Based Haemostats             
  • Combination Haemostats 
  • Fibrin Sealants       
  • Others      

Based on type, Thrombin based haemostats type is leading with the highest shares of the market. Gelatin based haemostats segment is to have the highest CAGR in the coming years. Growing awareness over the benefits of these devices in the medical sector magnifies these segments' growth rate. Besides, initiative steps by the government are also accelerating the demand of the market. 

Haemostatic Agents Market – By Treatment:

  • Cardiovascular       
  • General Surgery   
  • Digestive Surgery 
  • Neurosurgery        
  • Others      

Based on treatment, the cardiovascular segment is ruling with prominent shares of the market. Rise in cardiovascular problems due to changes in lifestyles and food habits are mainly fueling the demand of the market. General Surgery segment is holding the second position in leading the shares.

Haemostatic Agents Market – By End User:

  • Hospitals  
  • Surgery Centres    
  • Nursing Homes     
  • Others      

Based on end-user, the hospital's sector has dominant shares from the past years and is also to grow at a steady pace in foreseen years. The construction of hospitals and clinics with the latest technology is promoting the demand for this market.

Haemostatic Agents Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

The Haemostatic Agents Market is dominated by North America in 2019, with the region accounting for 36% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years, as is evident from the high CAGR value for the region. Another promising region for the market in Latin America, which is expected to show high growth rates in the coming years.

KEY MARKET PARTICIPANTS

The Haemostatic Agents market is highly competitive with a large number of players. Haemostatic Agents Industry Key players dominating the market with their products and services are Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, and Z-Medica.

RECENT MARKET DEVELOPMENTS

In June 2019, FDA approved VISTASEAL open and laparoscopic Dual applicators introduced Ethicon. These devices are used for next-generation technology and can be addressed for modern surgical bleeding. 

In December 2018, Baxter International Inc. introduced haemostatic agents for ENT surgical procedures, an additional curved applicator for Floseal.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Haemostatic Agents Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  3. Global Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  6. Global Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Others Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  11. Global Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  12. Global General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  13. Global Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  14. Global Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  15. Global Others Market, By Region, From 2020 to 2025 (USD Million)
  16. Global Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  17. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  18. Global Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  19. Global Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  20. Global Others Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  22. North America Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  23. North America Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  24. North America Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  25. North America Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  26. North America Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  27. North America Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  28. North America Others Market, By Region, From 2020 to 2025 (USD Million)
  29. North America Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  30. North America Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  31. North America General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  32. North America Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  33. North America Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  34. North America Others Market, By Region, From 2020 to 2025 (USD Million)
  35. North America Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  36. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  37. North America Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  38. North America Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  39. North America Others Market, By Region, From 2020 to 2025 (USD Million)
  40. United States Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  41. United States Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  42. United States Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  43. Canada Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  44. Canada Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  45. Canada Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  46. Europe Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  47. Europe Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  50. Europe Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  51. Europe Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  52. Europe Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  53. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  54. Europe Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  55. Europe Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  56. Europe General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  57. Europe Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  58. Europe Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  59. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  60. Europe Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  61. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  62. Europe Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  63. Europe Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  64. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  65. U.K. Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  66. U.K. Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  67. U.K. Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  68. Germany Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  69. Germany Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  70. Germany Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  71. France Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  72. France Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  73. France Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  74. Italy Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  75. Italy Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  76. Italy Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  77. Spain Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  78. Spain Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  79. Spain Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  80. Asia Pacific Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  81. Asia Pacific Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  82. Asia Pacific Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  83. Asia Pacific Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  84. Asia Pacific Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  85. Asia Pacific Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  86. Asia Pacific Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  87. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  88. Asia Pacific Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  89. Asia Pacific Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  90. Asia Pacific General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  91. Asia Pacific Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  92. Asia Pacific Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  93. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  94. Asia Pacific Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  95. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  96. Asia Pacific Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  97. Asia Pacific Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  98. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  99. Japan Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  100. Japan Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  101. Japan Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  102. China Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  103. China Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  104. China Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  105. India Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  106. India Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  107. India Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  108. Australia Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  109. Australia Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  110. Australia Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  111. South Korea Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  112. South Korea Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  113. South Korea Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  114. Latin America Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  115. Latin America Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  116. Latin America Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  117. Latin America Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  118. Latin America Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  119. Latin America Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  120. Latin America Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  121. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  122. Latin America Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  123. Latin America Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  124. Latin America General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  125. Latin America Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  126. Latin America Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  127. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  128. Latin America Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  129. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  130. Latin America Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  131. Latin America Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  132. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  133. Brazil Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  134. Brazil Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  135. Brazil Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  136. Argentina Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  137. Argentina Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  138. Argentina Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  139. Mexico Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  140. Mexico Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  141. Mexico Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  142. Rest of Latin America Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  143. Rest of Latin America Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  144. Rest of Latin America Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  145. Middle East and Africa Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  146. Middle East and Africa Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  147. Middle East and Africa Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  148. Middle East and Africa Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  149. Middle East and Africa Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  150. Middle East and Africa Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  151. Middle East and Africa Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  152. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Million)
  153. Middle East and Africa Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  154. Middle East and Africa Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  155. Middle East and Africa General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  156. Middle East and Africa Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  157. Middle East and Africa Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  158. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Million)
  159. Middle East and Africa Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  160. Middle East and Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  161. Middle East and Africa Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  162. Middle East and Africa Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  163. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Million)
  164. Middle East Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  165. Middle East Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  166. Middle East Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  167. Africa Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  168. Africa Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  169. Africa Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample